Brain-based vision loss, also known as cerebral or cortical visual impairment (CVI), is one of the leading causes of blindness and visual impairment in children in the United States and other industrialized nations. However, our understanding of CVI remains limited, and there is little consensus among healthcare providers on how to define and diagnose the condition.Researchers … [Read more...] about Understanding cerebral/cortical visual impairment: New insights and advances in diagnosis
News
VIDEO: ANXV shows early positive results in treatment of retinal vein occlusion
November 22, 2024 2 min watch CHICAGO — In this Healio Video Perspective from Eyecelerator@AAO, Anders Haegerstrand, MD, PhD, and Anna Frostegård, MD, PhD, of Annexin Pharmaceuticals discuss a phase 2a trial of ANXV for the treatment of retinal vein occlusion. “We achieved our main goals for the study,” Frostegård said. “We see that ANXV … [Read more...] about VIDEO: ANXV shows early positive results in treatment of retinal vein occlusion
IV- and opioid-free cataract surgery sedation tablet shows positive phase 3 results
November 22, 2024 1 min read Key takeaways: MELT-300 is a single tablet delivered sublingually for sedation during cataract surgery. It was statistically superior compared with sublingual midazolam and sublingual placebo. MELT-300 demonstrated in a pivotal phase 3 study positive topline results in IV- and opioid-free procedural … [Read more...] about IV- and opioid-free cataract surgery sedation tablet shows positive phase 3 results
AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases
AlloVir, Inc. has entered into a definitive merger agreement to combine with Kalaris Therapeutics in an all-stock transaction. Under the terms of the agreement, AlloVir will acquire 100% of the outstanding equity interest of Kalaris.According to the press release1, upon completion of the merger, pre-Merger AlloVir stockholders are expected to own approximately 25.05% of the … [Read more...] about AlloVir and Kalaris Therapeutics announce all-stock merger to focus on retinal diseases
Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy
A study led by Marie Elise Wistrup Torm, MD, reveals that combining noninvasive imaging techniques can detect microscopic abnormalities in diabetic retinopathy (DR) earlier and with greater detail than traditional fundus imaging. This suggests that these advanced methods offer a more precise, timely approach to diagnosing and managing DR, a leading cause of vision loss in … [Read more...] about Integrating imaging modalities for early detection of key microscopic abnormalities in diabetic retinopathy
Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform
Avant Technologies Inc. and its partner, Ainnova Tech Inc., have announced a collaboration to advance Ainnova’s proprietary low-cost retinal camera, designed for fundus photography. This camera will be integrated with Ainnova’s Vision AI software platform for commercialization, marking a significant step toward making retinal imaging more accessible in routine healthcare.By … [Read more...] about Avant Technologies and Ainnova Tech partner to advance retinal camera with AI-driven diagnostic platform
Self-reported visual function and in-depth swept-source optical coherence tomography features of cystoid macular edema in retinitis pigmentosa
Dias MF, Joo K, Kemp JA, Fialho SL, da Silva Cunha A Jr, Woo SJ, et al. Molecular genetics and emerging therapies for retinitis pigmentosa: basic research and clinical perspectives. Prog Retin Eye Res. 2018;63:107–31.Article CAS PubMed Google Scholar Marques JP, Ferreira N, Moreno N, Marta A, Vaz-Pereira S, Estrela-Silva S, … [Read more...] about Self-reported visual function and in-depth swept-source optical coherence tomography features of cystoid macular edema in retinitis pigmentosa
Retinal and choroidal microvascular assessment of children receiving recombinant growth hormone therapy
Growth hormone affects the growth of various body organs and the eyes. It was postulated that growth hormone reaches the eyes through the choroidal vasculature and shares in the retinal development [15]. Many studies showed the effects of GH and GHD on the retina and the optic disc. Still, none of them studied the impact of the recombinant growth hormone therapy on the vessel … [Read more...] about Retinal and choroidal microvascular assessment of children receiving recombinant growth hormone therapy
Healio | OSN announces editorial board appointments
November 21, 2024 1 min read Healio | OSN is proud to announce new board positions for Nicole R. Fram, MD, Kendall E. Donaldson, MD, MS, and Audrey R. Talley Rostov, MD. Fram, who previously served as Healio | OSN Cataract Surgery Section Editor, will now serve as Healio | OSN Associate Medical Editor, succeeding Elizabeth Yeu, MD. … [Read more...] about Healio | OSN announces editorial board appointments
Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results
Adverum Biotechnologies, Inc. announced topline 52-week results from the LUNA Phase 2 trial, new 4-year OPTIC long-term follow-up data, and key pivotal program design elements.Reaction to the dataLaurent Fischer, MD, president and chief executive officer of Adverum Biotechnologies shared his thoughts in the press release.1 He is quoted saying, “We are thrilled to report 52-week … [Read more...] about Adverum Biotechnologies announces topline 52-week results from LUNA Phase 2 trial and 4-year OPTIC results